WO2013041713A2 - System and apparatus for reactions - Google Patents

System and apparatus for reactions Download PDF

Info

Publication number
WO2013041713A2
WO2013041713A2 PCT/EP2012/068718 EP2012068718W WO2013041713A2 WO 2013041713 A2 WO2013041713 A2 WO 2013041713A2 EP 2012068718 W EP2012068718 W EP 2012068718W WO 2013041713 A2 WO2013041713 A2 WO 2013041713A2
Authority
WO
WIPO (PCT)
Prior art keywords
transfer device
reaction chamber
liquid transfer
fluid reservoir
housing
Prior art date
Application number
PCT/EP2012/068718
Other languages
French (fr)
Other versions
WO2013041713A3 (en
Inventor
Simon Roderick Grover
Paul Graham WILKINS
Nick David ROLLINGS
Peter Laurence MAYNE
Wai Ting Chan
Natalie Frances SCOTT
Olivier Fernand FLICK
Henry Charles INNES
Martyn Gray DARNBROUGH BEEDHAM
Nicholas David Long
Richard John HAMMOND
Original Assignee
Cambridge Medical Innovations Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46889055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2013041713(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to SI201231831T priority Critical patent/SI2758172T1/en
Priority to ES12762287T priority patent/ES2813939T3/en
Priority to CA2849193A priority patent/CA2849193C/en
Priority to RS20201042A priority patent/RS61271B1/en
Priority to CN201280043843.9A priority patent/CN103945941B/en
Priority to PL12762287T priority patent/PL2758172T3/en
Priority to JP2014531259A priority patent/JP5994158B2/en
Application filed by Cambridge Medical Innovations Limited filed Critical Cambridge Medical Innovations Limited
Priority to DK12762287.6T priority patent/DK2758172T3/en
Priority to AU2012311434A priority patent/AU2012311434B2/en
Priority to LTEP12762287.6T priority patent/LT2758172T/en
Priority to EP20177721.6A priority patent/EP3763440A3/en
Priority to EP12762287.6A priority patent/EP2758172B1/en
Publication of WO2013041713A2 publication Critical patent/WO2013041713A2/en
Publication of WO2013041713A3 publication Critical patent/WO2013041713A3/en
Priority to HK15101076.8A priority patent/HK1200399A1/en
Priority to HRP20201329TT priority patent/HRP20201329T1/en
Priority to CY20201100825T priority patent/CY1123331T1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/02—Burettes; Pipettes
    • B01L3/021—Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids
    • B01L3/0217—Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids of the plunger pump type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02—Adapting objects or devices to another
    • B01L2200/025—Align devices or objects to ensure defined positions relative to each other
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02—Adapting objects or devices to another
    • B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/16—Reagents, handling or storing thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/02—Identification, exchange or storage of information
    • B01L2300/025—Displaying results or values with integrated means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0478—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure pistons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575—Volumetric liquid transfer

Definitions

  • This invention relates to systems and apparatuses for liquid transfer and carrying out reactions.
  • the present disclosure provides systems, apparatuses and methods for transfer of liquids and processing of reactions, e.g., in diagnostic tests.
  • the disclosure features a system that includes a liquid transfer device that includes a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber.
  • the housing of the liquid transfer device can include a seal component configured to sealably engage with the reaction chamber.
  • the reaction chamber can include a seal component configured to sealably engage with the liquid transfer device.
  • the systems can further include a fluid reservoir, and the reaction chamber can optionally be configured to lockably engage with the fluid reservoir.
  • the liquid transfer device can be configured to lockably engage with the reaction chamber, e.g., without dispensing, prior to dispensing, and/or after dispensing a liquid sample.
  • the reaction chamber includes one or more components of a biological reaction.
  • the disclosure features a liquid transfer device that includes a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
  • movement of the housing relative to the plunger assembly results in creation of a vacuum within the pipette tip and, optionally, the plunger assembly can be configured to lock in a position resulting in creation of the vacuum.
  • the housing can be configured to move relative to the plunger assembly by pushing the housing down on the fluid reservoir.
  • the device can further be configured to provide an auditory and/or visual indication that the plunger assembly is in a position resulting in the creation of the vacuum.
  • a system can include the liquid transfer device and one or more of a fluid reservoir and reaction chamber.
  • the reaction chamber can be configured to unlock the plunger assembly when the liquid transfer device and the reaction chamber are interfaced.
  • the disclosure features a liquid transfer device configured to draw a sample from a fluid reservoir by pushing the device against the reservoir and systems that include the liquid transfer device and one or both of a reaction chamber and fluid reservoir.
  • two or all three of the liquid transfer device, reaction chamber, and fluid reservoir can have compatible asymmetric cross-sections.
  • the disclosure features methods that include (i) obtaining a liquid sample from a sample reservoir using a liquid transfer device described above; and (ii) dispensing the liquid sample, e.g., into a reaction chamber comprising one or more components of a reaction.
  • the disclosure features methods that include (i) obtaining a liquid sample from a fluid reservoir using a liquid transfer device (e.g., a liquid transfer device described above); and (ii) dispensing the liquid sample into a reaction chamber, wherein the liquid transfer device sealably engages with the reaction chamber during or prior to dispensing.
  • a liquid transfer device e.g., a liquid transfer device described above
  • the disclosure features methods that include (i) obtaining a liquid sample from a fluid reservoir using a liquid transfer device (e.g., a liquid transfer device described above); and (ii) dispensing the liquid sample into a reaction chamber, wherein the liquid transfer device lockably engages with the reaction chamber during or prior to dispensing.
  • the methods can further include (iii) interfacing the reaction chamber and the fluid reservoir, such that the reaction chamber lockably engages with the fluid reservoir.
  • the systems, apparatuses, and methods disclosed herein can provide for simple analysis of unprocessed biological specimens. They can be used with minimal scientific and technical knowledge, and any knowledge required may be obtained through simple instruction. They can be used with minimal and limited experience.
  • the systems and apparatuses allow for prepackaging or premeasuring of reagents, such that no special handling, precautions, or storage conditions are required.
  • the operational steps can be either automatically executed or easily controlled, e.g., through the use of auditory and/or visual indicators of operation of the systems and apparatuses.
  • FIG. 1 is an exploded view of an exemplary system as described herein.
  • FIGs. 2A-2C are exploded views of system subassemblies.
  • FIG. 2D is a view of the system mated and joined.
  • FIGs. 3A-3D depict the system in use.
  • FIG. 4 depicts the system in the context of an exemplary detection device.
  • FIGs. 5A-5C depict the system in cross-section during sample collection.
  • FIGs. 6A-6D depict the system in cross-section during sample dispensing.
  • FIGs. 7A-7B depict single (7 A) and double (7B) variants of the system.
  • This application describes systems, apparatuses, and methods for transfer of liquids and processing of biological reactions (e.g., nucleic acid amplification reactions).
  • the system can include three subassemblies: a transfer device 100, amplification chamber 200, and an elution container 300.
  • Each subassembly can have a D-shaped or otherwise asymmetrical cross section 105, 205, 305 that is compatible with the other two subassemblies, such that the subassemblies may only be mated to each other in one orientation.
  • the transfer device 100 includes a body 110 having a D-shaped or otherwise asymmetrical cross section 105 and a pipette tip 120.
  • the transfer device also includes a plunger unit 130 having a syringe plunger 135 that seals within the pipette tip 120 using an o-ring 140.
  • the plunger unit also includes flexible arms 131 having tabs 138 that are aligned with two sets of lower 112 and upper 113 slots in the body 110. Ridges within the body 110 align with grooves in the plunger unit 130 to guide the plunger unit 130 up and down within the body 110.
  • a spring 150 fits over a spring guide 139 of the plunger unit 130, and can be compressed against the cap 160 when the transfer device 100 is assembled.
  • an indicator 137 at the top of the spring guide 139 is visible through an indicator window 165 in the cap 160.
  • the amplification chamber 200 includes a body 210 having a D-shaped or otherwise asymmetrical cross-section 205 that is compatible with the cross-section 105 of the transfer device 100.
  • the amplification chamber body 210 also includes two tabs 215 that insert into either the lower slots 112 or upper slots 113 of the transfer device 100 when the two subassemblies are mated.
  • the reaction chamber 200 also includes a microtube 220 having a retaining ring 225 that holds the microtube 220 within an aperture in the bottom of the amplification chamber body 210.
  • the microtube 220 can also have a seal 228 that covers the mouth 223 of the tube 220.
  • the microtube 220 is optically permeable to allow monitoring of its contents.
  • the amplification chamber 200 also includes a sealing component 230 that fits within the amplification chamber body 210 and over the microtube 220, holding it in place.
  • the sealing component 230 includes a pliant gasket 235 configured to seal against the pipette housing 180 when the two subassemblies are mated (see FIGs. 6A-6D).
  • Two side tabs 240 are present near the bottom of the body 210 of the amplification chamber 200.
  • the elution container 300 has a D-shaped or otherwise asymmetrical cross-section 305 that is compatible with the cross-section 105 of the transfer device 100.
  • the elution container 300 includes an elution buffer reservoir 310 and a guide ring 320 compatible with a pipette housing 180 of the transfer device 100.
  • a seal can cover the mouth of the buffer reservoir 310 or guide ring 320.
  • Two notches 340 are present on the side walls 350 of the elution chamber 300, into which insert the side tabs 240 of the amplification chamber 200 when the two subassemblies are mated.
  • Fig. 2D shows the three subassemblies of the system mated and joined for disposal.
  • the transfer device 100 locks into the amplification chamber 200 by insertion of the amplification chamber tabs 215 into the upper slots 113 of the transfer device 100.
  • the amplification chamber 200 locks into the elution chamber 300 by insertion of the side tabs 240 of the amplification chamber 200 into the notches 340 of the elution chamber 300.
  • the patient sample and any amplified nucleic acids are sealed within the system to prevent contamination. Approximate dimensions of the joined system are shown.
  • FIGs. 3A-3D show an overview of the system in operation.
  • the transfer device 100 is positioned above the elution chamber 300 with their D-shaped cross-sections 105 and 305 aligned.
  • FIG. 3B the transfer device 100 is pushed down on the elution chamber 300, such that the pipette tip 120 enters the buffer reservoir 310 and the plunger unit 130 remains stationary relative to the body 110 due to contact with a guide ring on the buffer reservoir 310. This results in the plunger unit 130 in the upper position, compressing the spring 150 such that the indicator 137 shows through the indicator window 165.
  • the transfer device 100 has been removed from the elution chamber 300 and positioned above the amplification chamber 200 with their D-shaped cross-sections 105 and 205 aligned.
  • the transfer device 100 is pushed onto the amplification chamber 200.
  • the two tabs 215 of the amplification chamber 200 insert into the upper slots 113 of the transfer device 100, displacing the tabs 138 and allowing the compressed spring 150 to relax and the plunger unit 130 to return to the lower position.
  • the indicator 137 is no longer visible in the indicator window 165, signaling that the contents of the pipette tip 120 have been emptied into the microtube 220.
  • the transfer device 100 is locked into the amplification chamber 200 by insertion of the amplification chamber tabs 215 into the upper slots 113 of the transfer device 100.
  • FIG. 4 shows the system with an exemplary detection device 400.
  • the detection device 400 includes a first station 410 adapted to securely hold the elution chamber 300 and a second station 420 adapted to securely hold the amplification chamber 200.
  • the transfer device 100 is moved between the elution chamber 300 at the first station 410 and the amplification chamber 200 at the second station 420.
  • the detection device includes a lid 430 that can be closed when the detection device 400 is in operation or for storage.
  • a touchscreen user interface 440 is present for inputting data and displaying information regarding the assay.
  • the second station 420 can include a bar code reader or similar device to automatically detect a bar code or similar code present on the amplification chamber 200.
  • the first 410 and second 420 stations can be adapted to heat or cool the contents of the elution chamber 300 and reaction chamber 200.
  • the second station 420 can also be adapted to provide optical, fluorescence, or other monitoring and/or agitation of the microtube 220.
  • FIGs. 5A-5C show the system in cross-section during sample collection.
  • the transfer device 100 is placed above the elution chamber 300 such that their cross sections 105, 305 are aligned.
  • the plunger unit 130 is in the lower position and the tabs 138 are in the lower slots 112.
  • the transfer device 100 is lowered until one or more flanges 139 on the lower surface of the plunger unit 130 contact the guide ring 320, and the pipette tip 120 and plunger tip 132 are inserted into the liquid sample 360.
  • the liquid sample 360 can be a patient or other sample or include a patient or other sample dissolved or suspended in a buffer.
  • the transfer device 100 is pushed down by the user into the elution chamber 300.
  • the plunger unit 130 remains stationary through the contact of the one or more flanges 139 against the guide ring 320, while the transfer device body 110 is lowered relative to the plunger unit 130 and elution chamber 300.
  • a guide channel 116 in the transfer device is pushed downward relative to the guide ring 320.
  • the downward motion of the transfer device body 110 causes the pipette tip 120 to move downward relative to the plunger tip 132 and draw a liquid sample portion 365 into the pipette tip 120.
  • the downward motion of the transfer device body 110 relative to the plunger unit 130 also compresses the spring 150, moves the tabs 138 from the lower slots 112 to the upper slots 113, and causes the indicator 137 to be visible through the indicator window 165.
  • the transfer device 100 with the liquid sample portion 365 can now be lifted off of the elution chamber 300 and is ready for transfer and dispensing.
  • FIGs. 6A-6D show the system in cross-section during sample dispensing.
  • the transfer device 100 is placed above the amplification chamber 200 such that their cross sections 105, 205 are aligned.
  • the amplification chamber 200 is held within the second station 420 of the detection device 400 with the microtube 220 seated within a tube holder 428.
  • the transfer device 100 is lowered until two inner tabs 250 within the amplification chamber 200 engage two ridges 170 in the lower sides of the transfer device body 110, the tabs 215 insert into the lower slots 112 of the transfer device 100, and the gasket 235 engages the pipette housing 180.
  • the transfer device 100 is further lowered onto the amplification chamber 200, such that the amplification chamber tabs 215 insert into the upper slots 113 of the transfer device and displace the plunger unit tabs 138. Simultaneously, the pipette tip 120 pierces the seal 228 on the microtube 220.
  • the plunger unit 130 no longer held in the upper position, moves to the lower position as the spring 150 expands. This causes the plunger tip 132 to move downward within the pipette tip 120 and dispense the liquid sample portion 365 into the microtube 220.
  • the liquid sample portion 365 rehydrates a dried reagent pellet 280 in the microtube 220, initiating reaction (e.g., an amplification reaction).
  • initiating reaction e.g., an amplification reaction.
  • the transfer device 100 is locked in place on the amplification chamber 200 by the tabs 215 inserted into the upper slots 113, and any product of the amplification reaction is sealed within the unit by the gasket 235.
  • FIGs. 7A and 7B are three-quarter cross sections showing the system configured for one or two microtubes 220.
  • FIG. 7A shows the transfer device 100 and amplification chamber 200 as described above with one pipette tip 120 and one microtube 220.
  • FIG. 7B shows the transfer device 100 and amplification chamber 200 with two pipette tips 120 and two microtubes 220.
  • parallel reactions e.g., amplification reactions
  • the systems and apparatuses disclosed herein can be used to perform reactions, e.g., utilizing biological components.
  • the reactions involve production of nucleic acids, such as in nucleic acid amplification reactions.
  • Exemplary nucleic acid amplification reactions suitable for use with the disclosed apparatuses and systems include isothermal nucleic acid amplification reactions, e.g., strand displacement amplification, nicking and extension amplification reaction (NEAR) (see, e.g.,
  • RPA recombinase polymerase amplification
  • a microtube can contain one or more reagents or biological components, e.g., in dried form (see, e.g., WO 2010/141940), for carrying out a reaction.
  • the systems and apparatuses disclosed herein can be used to process various samples in reactions, e.g., utilizing biological components.
  • the samples can include biological samples, patient samples, veterinary samples, or environmental samples.
  • the reaction can be used to detect or monitor the existence or quantity of a specific target in the sample.
  • a portion of the sample is transferred using a transfer device as disclosed herein.
  • a liquid transfer device or pipette tip disclosed herein can be configured to collect and dispense a volume between 1 ⁇ and 5 ml (e.g., between any two of 1 ⁇ , 2 ⁇ , 5 ⁇ , 10 ⁇ , 20 ⁇ , 50 ⁇ , 100 ⁇ , 200 ⁇ , 500 ⁇ , 1 ml, 2 ml, and 5 ml).
  • kits that include one or more systems or apparatuses disclosed herein and one or more reagents for carrying out a reaction (e.g., a nucleic acid amplification reaction).
  • a reaction e.g., a nucleic acid amplification reaction
  • a transfer device as described herein can include three or more pipette tips. Accordingly, other embodiments are within the scope of the following claims.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cyclones (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)

Abstract

This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.

Description

SYSTEM AND APPARATUS FOR REACTIONS
TECHNICAL FIELD
This invention relates to systems and apparatuses for liquid transfer and carrying out reactions.
BACKGROUND
Many diagnostic tests that involve biological reactions are required to be performed in laboratories by skilled technicians and/or complex equipment. Such laboratories may be the subject of government regulation. The costs of compliance with such regulations can increase the costs of diagnostic tests to patients and health care payers and exclude such tests from point-of-care facilities. There is a need for systems for performing diagnostic tests involving biological reactions that can be used without extensive training at the point of care.
SUMMARY
The present disclosure provides systems, apparatuses and methods for transfer of liquids and processing of reactions, e.g., in diagnostic tests.
In one aspect, the disclosure features a system that includes a liquid transfer device that includes a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In some embodiments, the housing of the liquid transfer device can include a seal component configured to sealably engage with the reaction chamber. In some embodiments, the reaction chamber can include a seal component configured to sealably engage with the liquid transfer device. The systems can further include a fluid reservoir, and the reaction chamber can optionally be configured to lockably engage with the fluid reservoir.
The liquid transfer device can be configured to lockably engage with the reaction chamber, e.g., without dispensing, prior to dispensing, and/or after dispensing a liquid sample. In some embodiments, the reaction chamber includes one or more components of a biological reaction.
In another aspect, the disclosure features a liquid transfer device that includes a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
In some embodiments, movement of the housing relative to the plunger assembly results in creation of a vacuum within the pipette tip and, optionally, the plunger assembly can be configured to lock in a position resulting in creation of the vacuum. The housing can be configured to move relative to the plunger assembly by pushing the housing down on the fluid reservoir. The device can further be configured to provide an auditory and/or visual indication that the plunger assembly is in a position resulting in the creation of the vacuum.
A system can include the liquid transfer device and one or more of a fluid reservoir and reaction chamber. When a reaction chamber is included, the reaction chamber can be configured to unlock the plunger assembly when the liquid transfer device and the reaction chamber are interfaced.
In another aspect, the disclosure features a liquid transfer device configured to draw a sample from a fluid reservoir by pushing the device against the reservoir and systems that include the liquid transfer device and one or both of a reaction chamber and fluid reservoir.
In the systems described above, two or all three of the liquid transfer device, reaction chamber, and fluid reservoir can have compatible asymmetric cross-sections.
In another aspect, the disclosure features methods that include (i) obtaining a liquid sample from a sample reservoir using a liquid transfer device described above; and (ii) dispensing the liquid sample, e.g., into a reaction chamber comprising one or more components of a reaction.
In another aspect, the disclosure features methods that include (i) obtaining a liquid sample from a fluid reservoir using a liquid transfer device (e.g., a liquid transfer device described above); and (ii) dispensing the liquid sample into a reaction chamber, wherein the liquid transfer device sealably engages with the reaction chamber during or prior to dispensing.
In another aspect, the disclosure features methods that include (i) obtaining a liquid sample from a fluid reservoir using a liquid transfer device (e.g., a liquid transfer device described above); and (ii) dispensing the liquid sample into a reaction chamber, wherein the liquid transfer device lockably engages with the reaction chamber during or prior to dispensing. The methods can further include (iii) interfacing the reaction chamber and the fluid reservoir, such that the reaction chamber lockably engages with the fluid reservoir.
The systems, apparatuses, and methods disclosed herein can provide for simple analysis of unprocessed biological specimens. They can be used with minimal scientific and technical knowledge, and any knowledge required may be obtained through simple instruction. They can be used with minimal and limited experience. The systems and apparatuses allow for prepackaging or premeasuring of reagents, such that no special handling, precautions, or storage conditions are required. The operational steps can be either automatically executed or easily controlled, e.g., through the use of auditory and/or visual indicators of operation of the systems and apparatuses.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
DESCRIPTION OF DRAWINGS
FIG. 1 is an exploded view of an exemplary system as described herein.
FIGs. 2A-2C are exploded views of system subassemblies.
FIG. 2D is a view of the system mated and joined.
FIGs. 3A-3D depict the system in use.
FIG. 4 depicts the system in the context of an exemplary detection device.
FIGs. 5A-5C depict the system in cross-section during sample collection. FIGs. 6A-6D depict the system in cross-section during sample dispensing.
FIGs. 7A-7B depict single (7 A) and double (7B) variants of the system.
DETAILED DESCRIPTION
This application describes systems, apparatuses, and methods for transfer of liquids and processing of biological reactions (e.g., nucleic acid amplification reactions).
Referring to Fig. 1, the system can include three subassemblies: a transfer device 100, amplification chamber 200, and an elution container 300. Each subassembly can have a D-shaped or otherwise asymmetrical cross section 105, 205, 305 that is compatible with the other two subassemblies, such that the subassemblies may only be mated to each other in one orientation.
Figs. 2A-2C, show exploded views of the subassemblies 100, 200, and 300, respectively. In Fig. 2A, the transfer device 100 includes a body 110 having a D-shaped or otherwise asymmetrical cross section 105 and a pipette tip 120. The transfer device also includes a plunger unit 130 having a syringe plunger 135 that seals within the pipette tip 120 using an o-ring 140. The plunger unit also includes flexible arms 131 having tabs 138 that are aligned with two sets of lower 112 and upper 113 slots in the body 110. Ridges within the body 110 align with grooves in the plunger unit 130 to guide the plunger unit 130 up and down within the body 110. When the plunger unit 130 is in the lower position, the tabs 138 insert into the lower slots 112. When the plunger unit 130 is in the upper position, the tabs 138 insert into the upper slots 113. A spring 150 fits over a spring guide 139 of the plunger unit 130, and can be compressed against the cap 160 when the transfer device 100 is assembled. When the plunger unit 130 is in the upper position, an indicator 137 at the top of the spring guide 139 is visible through an indicator window 165 in the cap 160.
In Fig. 2B, the amplification chamber 200 includes a body 210 having a D-shaped or otherwise asymmetrical cross-section 205 that is compatible with the cross-section 105 of the transfer device 100. The amplification chamber body 210 also includes two tabs 215 that insert into either the lower slots 112 or upper slots 113 of the transfer device 100 when the two subassemblies are mated. The reaction chamber 200 also includes a microtube 220 having a retaining ring 225 that holds the microtube 220 within an aperture in the bottom of the amplification chamber body 210. The microtube 220 can also have a seal 228 that covers the mouth 223 of the tube 220. In some embodiments, the microtube 220 is optically permeable to allow monitoring of its contents. The amplification chamber 200 also includes a sealing component 230 that fits within the amplification chamber body 210 and over the microtube 220, holding it in place. The sealing component 230 includes a pliant gasket 235 configured to seal against the pipette housing 180 when the two subassemblies are mated (see FIGs. 6A-6D). Two side tabs 240 are present near the bottom of the body 210 of the amplification chamber 200.
In Fig. 2C, the elution container 300 has a D-shaped or otherwise asymmetrical cross-section 305 that is compatible with the cross-section 105 of the transfer device 100. The elution container 300 includes an elution buffer reservoir 310 and a guide ring 320 compatible with a pipette housing 180 of the transfer device 100. A seal can cover the mouth of the buffer reservoir 310 or guide ring 320. Two notches 340 are present on the side walls 350 of the elution chamber 300, into which insert the side tabs 240 of the amplification chamber 200 when the two subassemblies are mated.
Fig. 2D shows the three subassemblies of the system mated and joined for disposal. The transfer device 100 locks into the amplification chamber 200 by insertion of the amplification chamber tabs 215 into the upper slots 113 of the transfer device 100. Similarly, the amplification chamber 200 locks into the elution chamber 300 by insertion of the side tabs 240 of the amplification chamber 200 into the notches 340 of the elution chamber 300. In this configuration, the patient sample and any amplified nucleic acids are sealed within the system to prevent contamination. Approximate dimensions of the joined system are shown.
FIGs. 3A-3D show an overview of the system in operation. In Fig. 3A, the transfer device 100 is positioned above the elution chamber 300 with their D-shaped cross-sections 105 and 305 aligned. In FIG. 3B, the transfer device 100 is pushed down on the elution chamber 300, such that the pipette tip 120 enters the buffer reservoir 310 and the plunger unit 130 remains stationary relative to the body 110 due to contact with a guide ring on the buffer reservoir 310. This results in the plunger unit 130 in the upper position, compressing the spring 150 such that the indicator 137 shows through the indicator window 165. The presence of the indicator 137 in the indicator window 165 and an audible click as the tabs 138 insert into the upper slots 113 provide auditory and visual feedback that the transfer device has been manipulated properly such that the pipette tip 120 is able to withdraw a portion of the sample from the buffer reservoir 310. In FIG. 3C, the transfer device 100 has been removed from the elution chamber 300 and positioned above the amplification chamber 200 with their D-shaped cross-sections 105 and 205 aligned. In FIG. 3D, the transfer device 100 is pushed onto the amplification chamber 200. The two tabs 215 of the amplification chamber 200 insert into the upper slots 113 of the transfer device 100, displacing the tabs 138 and allowing the compressed spring 150 to relax and the plunger unit 130 to return to the lower position. The indicator 137 is no longer visible in the indicator window 165, signaling that the contents of the pipette tip 120 have been emptied into the microtube 220. The transfer device 100 is locked into the amplification chamber 200 by insertion of the amplification chamber tabs 215 into the upper slots 113 of the transfer device 100.
FIG. 4 shows the system with an exemplary detection device 400. The detection device 400 includes a first station 410 adapted to securely hold the elution chamber 300 and a second station 420 adapted to securely hold the amplification chamber 200. When in use, the transfer device 100 is moved between the elution chamber 300 at the first station 410 and the amplification chamber 200 at the second station 420. The detection device includes a lid 430 that can be closed when the detection device 400 is in operation or for storage. A touchscreen user interface 440 is present for inputting data and displaying information regarding the assay. The second station 420 can include a bar code reader or similar device to automatically detect a bar code or similar code present on the amplification chamber 200. The first 410 and second 420 stations can be adapted to heat or cool the contents of the elution chamber 300 and reaction chamber 200. The second station 420 can also be adapted to provide optical, fluorescence, or other monitoring and/or agitation of the microtube 220.
FIGs. 5A-5C show the system in cross-section during sample collection. In FIG. 5A, the transfer device 100 is placed above the elution chamber 300 such that their cross sections 105, 305 are aligned. The plunger unit 130 is in the lower position and the tabs 138 are in the lower slots 112. In FIG. 5B, the transfer device 100 is lowered until one or more flanges 139 on the lower surface of the plunger unit 130 contact the guide ring 320, and the pipette tip 120 and plunger tip 132 are inserted into the liquid sample 360. The liquid sample 360 can be a patient or other sample or include a patient or other sample dissolved or suspended in a buffer. In FIG. 5C, the transfer device 100 is pushed down by the user into the elution chamber 300. The plunger unit 130 remains stationary through the contact of the one or more flanges 139 against the guide ring 320, while the transfer device body 110 is lowered relative to the plunger unit 130 and elution chamber 300. Simultaneously, a guide channel 116 in the transfer device is pushed downward relative to the guide ring 320. The downward motion of the transfer device body 110 causes the pipette tip 120 to move downward relative to the plunger tip 132 and draw a liquid sample portion 365 into the pipette tip 120. The downward motion of the transfer device body 110 relative to the plunger unit 130 also compresses the spring 150, moves the tabs 138 from the lower slots 112 to the upper slots 113, and causes the indicator 137 to be visible through the indicator window 165. The transfer device 100 with the liquid sample portion 365 can now be lifted off of the elution chamber 300 and is ready for transfer and dispensing.
FIGs. 6A-6D show the system in cross-section during sample dispensing. In FIG. 6 A, the transfer device 100 is placed above the amplification chamber 200 such that their cross sections 105, 205 are aligned. The amplification chamber 200 is held within the second station 420 of the detection device 400 with the microtube 220 seated within a tube holder 428. In FIG. 6B, the transfer device 100 is lowered until two inner tabs 250 within the amplification chamber 200 engage two ridges 170 in the lower sides of the transfer device body 110, the tabs 215 insert into the lower slots 112 of the transfer device 100, and the gasket 235 engages the pipette housing 180. This prevents the transfer device 100 from being easily removed from the amplification chamber 200 once dispensing has been started and prevents release of the sample. In FIG. 6C, the transfer device 100 is further lowered onto the amplification chamber 200, such that the amplification chamber tabs 215 insert into the upper slots 113 of the transfer device and displace the plunger unit tabs 138. Simultaneously, the pipette tip 120 pierces the seal 228 on the microtube 220. In FIG. 6D, the plunger unit 130, no longer held in the upper position, moves to the lower position as the spring 150 expands. This causes the plunger tip 132 to move downward within the pipette tip 120 and dispense the liquid sample portion 365 into the microtube 220. The liquid sample portion 365 rehydrates a dried reagent pellet 280 in the microtube 220, initiating reaction (e.g., an amplification reaction). The transfer device 100 is locked in place on the amplification chamber 200 by the tabs 215 inserted into the upper slots 113, and any product of the amplification reaction is sealed within the unit by the gasket 235.
FIGs. 7A and 7B are three-quarter cross sections showing the system configured for one or two microtubes 220. FIG. 7A shows the transfer device 100 and amplification chamber 200 as described above with one pipette tip 120 and one microtube 220. FIG. 7B shows the transfer device 100 and amplification chamber 200 with two pipette tips 120 and two microtubes 220. Using the device in FIG. 7B, parallel reactions (e.g., amplification reactions) can be performed on two portions of one sample.
The systems and apparatuses disclosed herein can be used to perform reactions, e.g., utilizing biological components. In some embodiments, the reactions involve production of nucleic acids, such as in nucleic acid amplification reactions. Exemplary nucleic acid amplification reactions suitable for use with the disclosed apparatuses and systems include isothermal nucleic acid amplification reactions, e.g., strand displacement amplification, nicking and extension amplification reaction (NEAR) (see, e.g.,
US 2009/0081670), and recombinase polymerase amplification (RPA) (see, e.g.,
US 7,270,981; US 7,666,598). In some embodiments, a microtube can contain one or more reagents or biological components, e.g., in dried form (see, e.g., WO 2010/141940), for carrying out a reaction.
The systems and apparatuses disclosed herein can be used to process various samples in reactions, e.g., utilizing biological components. In some embodiments, the samples can include biological samples, patient samples, veterinary samples, or environmental samples. The reaction can be used to detect or monitor the existence or quantity of a specific target in the sample. In some embodiments, a portion of the sample is transferred using a transfer device as disclosed herein.
In some embodiments, a liquid transfer device or pipette tip disclosed herein can be configured to collect and dispense a volume between 1 μΐ and 5 ml (e.g., between any two of 1 μΐ, 2 μΐ, 5 μΐ, 10 μΐ, 20 μΐ, 50 μΐ, 100 μΐ, 200 μΐ, 500 μΐ, 1 ml, 2 ml, and 5 ml).
The disclosure also features articles of manufacture (e.g., kits) that include one or more systems or apparatuses disclosed herein and one or more reagents for carrying out a reaction (e.g., a nucleic acid amplification reaction).
A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. For example, a transfer device as described herein can include three or more pipette tips. Accordingly, other embodiments are within the scope of the following claims.

Claims

WHAT IS CLAIMED IS:
1. A system comprising:
a liquid transfer device comprising a housing having a pipette tip and a plunger assembly; and
a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber.
2. The system of claim 1, wherein the housing of the liquid transfer device comprises a seal component configured to sealably engage with the reaction chamber.
3. The system of claim 1, wherein the reaction chamber comprises a seal component configured to sealably engage with the liquid transfer device.
4. The system of claim 1, wherein the liquid transfer device is configured to lockably engage with the reaction chamber.
5. The system of claim 4, wherein the liquid transfer device is configured to lockably engage with the reaction chamber without dispensing.
6. The system of claim 4, wherein the liquid transfer device is configured to lockably engage with the reaction chamber after dispensing.
7. The system of claim 1, wherein the reaction chamber comprises one or more components of a biological reaction.
8. The system of claim 1, further comprising a fluid reservoir.
9. The system of claim 8, wherein the reaction chamber is configured to lockably engage with the fluid reservoir.
10. A liquid transfer device comprising:
a housing comprising a pipette tip; and
a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
11. The liquid transfer device of claim 10, wherein movement of the housing relative to the plunger assembly results in creation of a vacuum within the pipette tip.
12. The liquid transfer device of claim 10, wherein the housing is configured to move relative to the plunger assembly by pushing the housing down on the fluid reservoir.
13. The liquid transfer device of claim 11, wherein the plunger assembly is configured to lock in a position resulting in creation of the vacuum.
14. The liquid transfer device of claim 11, wherein the device is configured to provide an auditory and/or visual indication that the plunger assembly is in a position resulting in the creation of the vacuum.
15. A system comprising the liquid transfer device of claim 10 and a fluid reservoir.
16. A system comprising the liquid transfer device of claim 13 and a reaction chamber, wherein the reaction chamber is configured to unlock the plunger assembly when the liquid transfer device and the reaction chamber are interfaced.
17. The system of claim 16, further comprising a fluid reservoir.
A method comprising (i) obtaining a liquid sample from a sample reservoir using the liquid transfer device of claim 10; and
(ii) dispensing the liquid sample.
19. The method of claim 18, wherein dispensing the liquid sample comprises dispensing the liquid sample into a reaction chamber comprising one or more components of a reaction.
20. A method comprising:
(i) obtaining a liquid sample from a fluid reservoir using a liquid transfer device; and
(ii) dispensing the liquid sample into a reaction chamber, wherein the liquid transfer device sealably engages with the reaction chamber during or prior to dispensing.
21. A method comprising:
(i) obtaining a liquid sample from a fluid reservoir using a liquid transfer device; and
(ii) dispensing the liquid sample into a reaction chamber, wherein the liquid transfer device lockably engages with the reaction chamber during or prior to dispensing.
22. The method of claim 21, further comprising:
(iii) interfacing the reaction chamber and the fluid reservoir, such that the reaction chamber lockably engages with the fluid reservoir.
23. The system of claim 1 or 16, wherein the liquid transfer device and the reaction chamber have compatible asymmetric cross-sections.
24. The system of claim 8, wherein the reaction chamber and the fluid reservoir have compatible asymmetric cross-sections.
25. A liquid transfer device configured to draw a sample from a fluid reservoir by pushing the device against the reservoir.
PCT/EP2012/068718 2011-09-23 2012-09-21 System and apparatus for reactions WO2013041713A2 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DK12762287.6T DK2758172T3 (en) 2011-09-23 2012-09-21 SYSTEM FOR PERFORMING REACTIONS
AU2012311434A AU2012311434B2 (en) 2011-09-23 2012-09-21 System and apparatus for reactions
ES12762287T ES2813939T3 (en) 2011-09-23 2012-09-21 Reaction system
LTEP12762287.6T LT2758172T (en) 2011-09-23 2012-09-21 System for carrying out reactions
CN201280043843.9A CN103945941B (en) 2011-09-23 2012-09-21 For the system of reacting and device
PL12762287T PL2758172T3 (en) 2011-09-23 2012-09-21 System for carrying out reactions
JP2014531259A JP5994158B2 (en) 2011-09-23 2012-09-21 Reaction system and equipment
SI201231831T SI2758172T1 (en) 2011-09-23 2012-09-21 System for carrying out reactions
EP12762287.6A EP2758172B1 (en) 2011-09-23 2012-09-21 System for carrying out reactions
CA2849193A CA2849193C (en) 2011-09-23 2012-09-21 System and apparatus for reactions
RS20201042A RS61271B1 (en) 2011-09-23 2012-09-21 System for carrying out reactions
EP20177721.6A EP3763440A3 (en) 2011-09-23 2012-09-21 System and apparatus for reactions
HK15101076.8A HK1200399A1 (en) 2011-09-23 2015-01-30 System and apparatus for reactions
HRP20201329TT HRP20201329T1 (en) 2011-09-23 2020-08-25 System for carrying out reactions
CY20201100825T CY1123331T1 (en) 2011-09-23 2020-09-02 REACTION EXECUTION SYSTEM

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/242,999 2011-09-23
US13/242,999 US9352312B2 (en) 2011-09-23 2011-09-23 System and apparatus for reactions

Publications (2)

Publication Number Publication Date
WO2013041713A2 true WO2013041713A2 (en) 2013-03-28
WO2013041713A3 WO2013041713A3 (en) 2013-07-04

Family

ID=46889055

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/068718 WO2013041713A2 (en) 2011-09-23 2012-09-21 System and apparatus for reactions

Country Status (18)

Country Link
US (4) US9352312B2 (en)
EP (2) EP2758172B1 (en)
JP (1) JP5994158B2 (en)
CN (3) CN105181390B (en)
AU (2) AU2012311434B2 (en)
CA (1) CA2849193C (en)
CY (1) CY1123331T1 (en)
DK (1) DK2758172T3 (en)
ES (1) ES2813939T3 (en)
HK (1) HK1200399A1 (en)
HR (1) HRP20201329T1 (en)
HU (1) HUE050654T2 (en)
LT (1) LT2758172T (en)
PL (1) PL2758172T3 (en)
PT (1) PT2758172T (en)
RS (1) RS61271B1 (en)
SI (1) SI2758172T1 (en)
WO (1) WO2013041713A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10040061B2 (en) 2011-09-23 2018-08-07 Alere Switzerland Gmbh System and apparatus for reactions
US11185864B2 (en) 2015-11-05 2021-11-30 Alere San Diego, Inc. Sample preparation device

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015138343A1 (en) 2014-03-10 2015-09-17 Click Diagnostics, Inc. Cartridge-based thermocycler
US9623415B2 (en) 2014-12-31 2017-04-18 Click Diagnostics, Inc. Devices and methods for molecular diagnostic testing
WO2016188430A1 (en) * 2015-05-25 2016-12-01 Coyote Bioscience Co., Ltd. Devices and methods for sample collection cross-reference
GB201510723D0 (en) * 2015-06-18 2015-08-05 Alere Switzerland Gmbh High throughput isothermal nucleic acid amplification
CN107849508A (en) 2015-07-13 2018-03-27 卡尤迪生物科技（北京）有限公司 Apparatus and method for sample collection
JP6778271B2 (en) * 2015-11-04 2020-10-28 日東電工株式会社 Equipment and systems for dispensing and / or analyzing biofluidic samples
USD799027S1 (en) * 2016-01-28 2017-10-03 Coltene/Whaledent Gmbh & Co. Kg Modular filling station for filling syringes
USD799693S1 (en) * 2016-01-28 2017-10-10 Coltene/Whaledent Gmbh & Co. Kg Bottle holder for a modular filling station for filling syringes
CN108852828A (en) * 2016-03-14 2018-11-23 石家庄四药有限公司 A kind of infusion bottle（Bag）Integrated hanging ring and its manufacturing method
US10987674B2 (en) 2016-04-22 2021-04-27 Visby Medical, Inc. Printed circuit board heater for an amplification module
WO2017197040A1 (en) 2016-05-11 2017-11-16 Click Diagnostics, Inc. Devices and methods for nucleic acid extraction
USD800331S1 (en) 2016-06-29 2017-10-17 Click Diagnostics, Inc. Molecular diagnostic device
EP3478857A1 (en) 2016-06-29 2019-05-08 Click Diagnostics, Inc. Devices and methods for the detection of molecules using a flow cell
USD800913S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Detection window for molecular diagnostic device
USD800914S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Status indicator for molecular diagnostic device
CA3078976A1 (en) 2017-11-09 2019-05-16 Visby Medical, Inc. Portable molecular diagnostic device and methods for the detection of target viruses
WO2021138544A1 (en) 2020-01-03 2021-07-08 Visby Medical, Inc. Devices and methods for antibiotic susceptibility testing
CN115077996A (en) * 2021-03-15 2022-09-20 富佳生技股份有限公司 Pipetting system
US20220097040A1 (en) * 2020-09-30 2022-03-31 Icare Diagnostics International Co. Ltd. Liquid transfer device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270981B2 (en) 2002-02-21 2007-09-18 Asm Scientific, Inc. Recombinase polymerase amplification
US20090081670A1 (en) 2007-07-14 2009-03-26 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US7666598B2 (en) 2002-02-21 2010-02-23 Twistdx, Inc. Recombinase polymerase amplification
WO2010141940A1 (en) 2009-06-05 2010-12-09 Alere San Diego, Inc. Recombinase polymerase amplification reagents and kits

Family Cites Families (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US726629A (en) * 1902-12-17 1903-04-28 B W Automatic Jar & Bottle Company Jar-closure.
US3430628A (en) * 1965-02-23 1969-03-04 Reatha L Wiggins Plurality of aspirators
US3444742A (en) * 1965-12-06 1969-05-20 Univ Of Kentucky Research Foun Multiple-unit pipetting assembly and pipette for use therein
US3389835A (en) 1967-09-19 1968-06-25 Jacob P. Marbach Stationary analytical sampling device
US3572552A (en) * 1969-07-25 1971-03-30 Perry W Guinn Diaphragm dispenser
US3653839A (en) * 1970-07-06 1972-04-04 Henry Valve Co Field test kit reagent transferring system and method for using same
US3855868A (en) * 1972-02-10 1974-12-24 O Sudvaniemi Multiple pipette
US3827305A (en) * 1972-10-24 1974-08-06 R Gilson Adjustable pipette
FI55093C (en) * 1974-07-05 1979-05-10 Osmo Antero Suovaniemi FOERFARANDE FOER EXAKT MAETNING AV ABSORPTION AV SMAO VAETSKEMAENGDER SAMT ANORDNING FOER DESS GENOMFOERANDE
US4047438A (en) * 1975-04-04 1977-09-13 Teruaki Sekine Liquid quantitative dispensing apparatus
US4153057A (en) 1975-07-24 1979-05-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Stopper for two-chamber mixing syringe
US4258761A (en) * 1979-05-03 1981-03-31 Bennett John T Jr Rehydrator
US4466426A (en) 1981-06-29 1984-08-21 Blackman Seymour N Syringe with actinic ray blocking stripe
US4498510A (en) * 1982-08-20 1985-02-12 Minshew Jr Edward C Device for drawing, holding and dispensing liquid
EP0189900B1 (en) * 1985-01-29 1989-04-05 Fuji Photo Film Co., Ltd. Duplex pipette
JPS63128259A (en) * 1986-11-18 1988-05-31 Yasunobu Tsukioka Method and device for cleaning reaction bead for inspecting blood or the like
US4921618A (en) * 1987-07-01 1990-05-01 Basf Corporation Inverted separation and transfer device, and process for using same
US5273879A (en) 1987-07-23 1993-12-28 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
WO1989007730A1 (en) * 1988-02-22 1989-08-24 Claude Jaggi Coupling, in particular quick-acting coupling for fluid lines
CN1018291B (en) * 1988-07-26 1992-09-16 克洛德·雅基 Coupling, in particular quick-acting coupling for fluid conduits
US5152965A (en) * 1989-06-02 1992-10-06 Abbott Laboratories Two-piece reagent container assembly
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5114411A (en) * 1990-11-19 1992-05-19 Habley Medical Technology Corporation Multi-chamber vial
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5556751A (en) 1991-04-25 1996-09-17 Amoco Corporation Selective amplification system using Q-β replicase
EP0515883B1 (en) * 1991-05-28 1995-05-03 Dade International Inc. Device for safe sampling of blood from a container
US5846717A (en) 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
FR2683827B1 (en) 1991-11-15 1994-03-04 Institut Nal Sante Recherc Medic METHOD FOR DETERMINING THE QUANTITY OF A FRAGMENT OF DNA OF INTEREST BY AN ENZYMATIC AMPLIFICATION METHOD.
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US5614389A (en) 1992-08-04 1997-03-25 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
WO1994003624A1 (en) 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US5733733A (en) 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5834202A (en) 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
JP3316005B2 (en) * 1992-08-31 2002-08-19 大成化工株式会社 Multi-cylinder connection mechanism between drug container and solution container
US5343909A (en) * 1992-12-17 1994-09-06 Jack Goodman Liquid transfer device
US5470723A (en) 1993-05-05 1995-11-28 Becton, Dickinson And Company Detection of mycobacteria by multiplex nucleic acid amplification
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
EP0725593B1 (en) * 1993-10-28 2004-04-07 I-Stat Corporation Fluid sample collection and introduction device
CA2185239C (en) 1994-03-16 2002-12-17 Nanibhushan Dattagupta Isothermal strand displacement nucleic acid amplification
US5547861A (en) 1994-04-18 1996-08-20 Becton, Dickinson And Company Detection of nucleic acid amplification
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5942391A (en) 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
JP3389352B2 (en) * 1994-10-20 2003-03-24 三洋電機株式会社 Liquid dispensing device
EP1260593A3 (en) 1994-12-23 2003-12-03 Dade Behring Inc. Detection of nucleic acids by nuclease-catalyzed product formation
AUPN245295A0 (en) 1995-04-13 1995-05-11 Johnson & Johnson Research Pty. Limited Assay for genetic abnormalities
AT402203B (en) 1995-06-13 1997-03-25 Himmler Gottfried Dipl Ing Dr METHOD FOR TRANSCRIPTION-FREE AMPLIFICATION OF NUCLEIC ACIDS
US5681705A (en) 1995-08-28 1997-10-28 Schram; James L. Amplification and detection of mycobacterium avium complex species
US5916779A (en) 1995-09-21 1999-06-29 Becton, Dickinson And Company Strand displacement amplification of RNA targets
FI954511A0 (en) 1995-09-22 1995-09-22 Labsystems Oy fluorometer
US5747255A (en) 1995-09-29 1998-05-05 Lynx Therapeutics, Inc. Polynucleotide detection by isothermal amplification using cleavable oligonucleotides
JP2000500671A (en) 1995-11-13 2000-01-25 コーテックス（ユーケー）リミテッド Diagnostic test equipment
US5985557A (en) 1996-01-24 1999-11-16 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
US7432048B2 (en) 1996-11-29 2008-10-07 Third Wave Technologies, Inc. Reactions on a solid surface
AU723678B2 (en) 1996-03-18 2000-08-31 Molecular Biology Resources, Inc. Target nucleic acid sequence amplification
US7244622B2 (en) 1996-04-03 2007-07-17 Applera Corporation Device and method for multiple analyte detection
DE69736667T2 (en) 1996-07-16 2007-09-06 Gen-Probe Inc., San Diego PROCESS FOR THE DETECTION AND AMPLIFICATION OF NUCLEIC ACID SEQUENCES USING MODIFIED OLIGONUCLEOTIDES WITH INCREASED TARGET MELT TEMPERATURE (TM)
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5853990A (en) 1996-07-26 1998-12-29 Edward E. Winger Real time homogeneous nucleotide assay
FR2753624B1 (en) * 1996-09-25 1999-04-16 Biodome CONNECTION DEVICE, PARTICULARLY BETWEEN A CONTAINER WITH PERFORABLE CAP AND A SYRINGE
US6514461B1 (en) 1997-02-14 2003-02-04 Escreen, Inc. System for automatically testing a fluid specimen
US6197557B1 (en) 1997-03-05 2001-03-06 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
US6117634A (en) 1997-03-05 2000-09-12 The Reagents Of The University Of Michigan Nucleic acid sequencing and mapping
US5928869A (en) 1997-05-30 1999-07-27 Becton, Dickinson And Company Detection of nucleic acids by fluorescence quenching
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
JP4317953B2 (en) 1998-01-22 2009-08-19 独立行政法人理化学研究所 DNA sequence determination method
GB9827152D0 (en) 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6287825B1 (en) 1998-09-18 2001-09-11 Molecular Staging Inc. Methods for reducing the complexity of DNA sequences
CN1248495A (en) * 1998-09-22 2000-03-29 陈国君 Quick adjustable pipette
AU1908100A (en) 1998-11-06 2000-05-29 Molecular Biology Resources, Inc. Isothermal nucleic acid amplification methods
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
DE19956568A1 (en) 1999-01-30 2000-08-17 Roland Kreutzer Method and medicament for inhibiting the expression of a given gene
US6316200B1 (en) 2000-06-08 2001-11-13 Becton, Dickinson And Company Probes and methods for detection of nucleic acids
WO2001029058A1 (en) 1999-10-15 2001-04-26 University Of Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6893819B1 (en) 2000-11-21 2005-05-17 Stratagene California Methods for detection of a nucleic acid by sequential amplification
US6852986B1 (en) 1999-11-12 2005-02-08 E. I. Du Pont De Nemours And Company Fluorometer with low heat-generating light source
GB9927444D0 (en) 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
US6191267B1 (en) 2000-06-02 2001-02-20 New England Biolabs, Inc. Cloning and producing the N.BstNBI nicking endonuclease
CN2447765Y (en) * 2000-09-05 2001-09-12 王振明 Pipet
US6350580B1 (en) 2000-10-11 2002-02-26 Stratagene Methods for detection of a target nucleic acid using a probe comprising secondary structure
US6924104B2 (en) 2000-10-27 2005-08-02 Yale University Methods for identifying genes associated with diseases or specific phenotypes
WO2002061133A2 (en) 2000-11-09 2002-08-08 Yale University Nucleic acid detection using structured probes
US7309573B2 (en) 2000-11-21 2007-12-18 Stratagene California Methods for detection of a nucleic acid by sequential amplification
FI20002761A0 (en) * 2000-12-15 2000-12-15 Wallac Oy Multi-channel pipette device
US6958217B2 (en) 2001-01-24 2005-10-25 Genomic Expression Aps Single-stranded polynucleotide tags
FI20010972A0 (en) * 2001-05-09 2001-05-09 Thermo Labsystems Oy Spetsbehållarpipett
US6800491B2 (en) * 2001-06-08 2004-10-05 Nalge Nunc International Corporation Robotic reservoir without liquid hangup
AU2002318253A1 (en) 2001-07-15 2003-03-03 Keck Graduate Institute Methylation analysis using nicking agents
WO2004022701A2 (en) 2001-07-15 2004-03-18 Keck Graduate Institute Exponential amplification of nucleic acids using nicking agents
CA2492220C (en) 2001-07-15 2014-03-18 Keck Graduate Institute Nucleic acid amplification using nicking agents
US6632611B2 (en) 2001-07-20 2003-10-14 Affymetrix, Inc. Method of target enrichment and amplification
FR2829691B1 (en) * 2001-09-17 2004-07-09 Sedat DEVICE FOR BIDIRECTIONAL TRANSFER OF A LIQUID BETWEEN A BOTTLE AND A CARPULE
US6617137B2 (en) 2001-10-15 2003-09-09 Molecular Staging Inc. Method of amplifying whole genomes without subjecting the genome to denaturing conditions
US7373253B2 (en) 2002-02-12 2008-05-13 Idaho Technology Multi-test analysis of real-time nucleic acid amplification
DE60300580T2 (en) * 2002-02-12 2006-01-19 Biotage Ab SEPARATION METHOD AND DEVICE FOR IMPLEMENTING SUCH A METHOD
FR2836832B1 (en) * 2002-03-08 2005-02-04 Optis France Sa CONNECTION ASSEMBLY FOR MEDICAL USE FOR THE TRANSFER OF FLUIDS
GB0207063D0 (en) 2002-03-26 2002-05-08 Amersham Biosciences Uk Ltd Immobilised probes
EP1385006A3 (en) 2002-07-24 2004-09-01 F. Hoffmann-La Roche Ag System and cartridge for processing a biological sample
US7662594B2 (en) 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
WO2004027025A2 (en) 2002-09-20 2004-04-01 New England Biolabs, Inc. Helicase dependent amplification of nucleic acids
WO2004067764A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Nucleic acid sequencing using nicking agents
US7125727B2 (en) * 2003-01-29 2006-10-24 Protedyne Corporation Sample handling tool with piezoelectric actuator
WO2004067726A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Isothermal reactions for the amplification of oligonucleotides
US20040209299A1 (en) 2003-03-07 2004-10-21 Rubicon Genomics, Inc. In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
TW587693U (en) * 2003-03-14 2004-05-11 Mau-Guei Jang Attaching and stirring type quantitative excrements inspection device
TWI375796B (en) 2003-04-18 2012-11-01 Becton Dickinson Co Immuno-amplification
AU2004235349B2 (en) 2003-04-25 2009-11-19 Becton, Dickinson And Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
WO2005026329A2 (en) 2003-09-12 2005-03-24 Cornell Research Foundation, Inc. Methods for identifying target nucleic acid molecules
US20050069939A1 (en) 2003-09-26 2005-03-31 Youxiang Wang Amplification of polynucleotides by rolling circle amplification
NZ547175A (en) 2003-11-14 2009-11-27 Oakville Hong Kong Co Ltd Sample collection cup with integrated sample analysis system
CA2549297C (en) 2003-12-16 2012-11-27 Idexx Laboratories, Inc. Tissue sampling device and method
US7314714B2 (en) 2003-12-19 2008-01-01 Affymetrix, Inc. Method of oligonucleotide synthesis
CA2559209C (en) 2004-03-08 2016-06-07 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
US20050233332A1 (en) 2004-04-14 2005-10-20 Collis Matthew P Multiple fluorophore detector system
ES2718482T3 (en) 2004-06-01 2019-07-02 Alere San Diego Inc Recombinase polymerase amplification kit
US8206650B2 (en) 2005-04-12 2012-06-26 Chromedx Inc. Joint-diagnostic spectroscopic and biosensor meter
CN1900680A (en) * 2005-07-18 2007-01-24 全谱科技股份有限公司 Sensing device for micro quanlity split injector
US20070020151A1 (en) * 2005-07-20 2007-01-25 Steven Woodside Pipette tip holder
US20070020639A1 (en) 2005-07-20 2007-01-25 Affymetrix, Inc. Isothermal locus specific amplification
ATE510930T1 (en) 2005-08-02 2011-06-15 Rubicon Genomics Inc COMPOSITIONS AND METHODS FOR EDITING AND AMPLIFICATION OF DNA USING MULTIPLE ENZYMES IN A SINGLE REACTION
DE102005041183B3 (en) * 2005-08-31 2007-01-04 Eppendorf Ag Two-part pipetting system for metering liquids, has lower spigot which is secured in its holder by snap hooks with catches and released by wedge system actuated by movement of unlocking ring
CN100478671C (en) 2005-10-25 2009-04-15 艾康生物技术(杭州)有限公司 Detector and method for liquid sampler
EP1878498A1 (en) 2006-07-14 2008-01-16 Roche Diagnostics GmbH Handling kit for analyzing a liquid sample by nucleic acid ampification
CN101686896B (en) 2007-04-23 2014-07-09 普拉斯特米德有限公司 Method and apparatus for contamination-free transfer of a hazardous drug
CN201271367Y (en) * 2008-09-20 2009-07-15 陈玉嵩 Novel safe agent box
JP2012528692A (en) 2009-06-02 2012-11-15 ユーコン・メディカル，リミテッド・ライアビリティ・カンパニー Multi-container transfer / delivery device
EP2302029A1 (en) 2009-09-29 2011-03-30 Fundacion Gaiker Portable enrichment, aliquoting, and testing device of microorganisms and toxins
WO2011073174A1 (en) 2009-12-15 2011-06-23 Novartis Ag Syringe
JP2011182728A (en) * 2010-03-10 2011-09-22 Seiko Epson Corp Reaction container and reaction method
US9352312B2 (en) * 2011-09-23 2016-05-31 Alere Switzerland Gmbh System and apparatus for reactions
GB201519565D0 (en) * 2015-11-05 2015-12-23 Alere San Diego Inc Sample preparation device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270981B2 (en) 2002-02-21 2007-09-18 Asm Scientific, Inc. Recombinase polymerase amplification
US7666598B2 (en) 2002-02-21 2010-02-23 Twistdx, Inc. Recombinase polymerase amplification
US20090081670A1 (en) 2007-07-14 2009-03-26 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
WO2010141940A1 (en) 2009-06-05 2010-12-09 Alere San Diego, Inc. Recombinase polymerase amplification reagents and kits

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10040061B2 (en) 2011-09-23 2018-08-07 Alere Switzerland Gmbh System and apparatus for reactions
US11033894B2 (en) 2011-09-23 2021-06-15 Abbott Diagnostics Scarborough, Inc. System and apparatus for reactions
US11185864B2 (en) 2015-11-05 2021-11-30 Alere San Diego, Inc. Sample preparation device
EP3978120A1 (en) 2015-11-05 2022-04-06 Abbott Diagnostics Scarborough, Inc. Sample preparation device

Also Published As

Publication number Publication date
SI2758172T1 (en) 2020-10-30
PT2758172T (en) 2020-09-04
CN105170202B (en) 2017-10-27
WO2013041713A3 (en) 2013-07-04
JP5994158B2 (en) 2016-09-21
EP2758172B1 (en) 2020-06-03
EP2758172A2 (en) 2014-07-30
US10040061B2 (en) 2018-08-07
EP3763440A2 (en) 2021-01-13
AU2016200920B2 (en) 2016-10-20
LT2758172T (en) 2020-10-26
PL2758172T3 (en) 2021-02-08
EP3763440A3 (en) 2021-05-05
CY1123331T1 (en) 2022-03-24
CA2849193A1 (en) 2013-03-28
CN103945941A (en) 2014-07-23
AU2012311434B2 (en) 2015-12-10
HK1200399A1 (en) 2015-11-27
US20130078736A1 (en) 2013-03-28
US11033894B2 (en) 2021-06-15
CN105181390A (en) 2015-12-23
CN103945941B (en) 2015-09-30
AU2016200920A1 (en) 2016-03-03
CN105181390B (en) 2019-07-16
RS61271B1 (en) 2021-01-29
AU2012311434A1 (en) 2014-03-27
US9352312B2 (en) 2016-05-31
US20210316297A1 (en) 2021-10-14
DK2758172T3 (en) 2020-08-31
HRP20201329T1 (en) 2020-11-27
ES2813939T3 (en) 2021-03-25
US20160288116A1 (en) 2016-10-06
JP2014528075A (en) 2014-10-23
CN105170202A (en) 2015-12-23
HUE050654T2 (en) 2020-12-28
CA2849193C (en) 2018-07-17
US20190039059A1 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
US11033894B2 (en) System and apparatus for reactions
EP2179294B1 (en) Sample processor
EP2049261B1 (en) Device, system and method for processing a sample
CN108779458B (en) Sample preparation system and cartridge
US20070048194A1 (en) Use of a disposable container, microfluidic device and method for processing molecules
JP2014098595A (en) Sample liquid injection tool and sample liquid heat treatment apparatus
US20230381770A1 (en) Sample Preparation Cartridge and System
WO2022187609A9 (en) Fluid handling device for a biological container
GB2568377A (en) Sample preparation system and cartridge

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12762287

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012762287

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2849193

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2014531259

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2012311434

Country of ref document: AU

Date of ref document: 20120921

Kind code of ref document: A